The relative burden of haemophilia A and the impact of target joint development on health-related quality of life: Results from the ADVATE Post-Authorization Safety Surveillance (PASS) study

Haemophilia

Volumn 17, Issue 3, 2011, Pages 412-421

  Klamroth, R ^a   Pollmann, H ^b   Hermans, C ^c   Faradji, A ^d   Yarlas, A S ^e   Epstein, J D ^f   Ewenstein, B M ^f  

^a Vivantes Klinikum in Friedrichhain   (Germany)

^b Raphaels Klinik Munster GmbH   (Germany)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d HÔPITAL DE HAUTEPIERRE   (France)

^e QualityMetric   (United States)

^f BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Burden analysis; Haemophilia A; Health related quality of life; Target joint

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 8;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BACKACHE; CHRONIC PAIN; DIABETES MELLITUS; HEMOPHILIA A; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SHORT FORM 36;

EID: 79955129252     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02435.x     Document Type: Article

References (31)

1. World Federation of Hemophilia. Guidelines for the Management of Hemophilia. Montréal, QC: World Federation of Hemophilia, 2005.
2. Darby SC, Kan SW, Spooner RJ et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007; 110: 815-25.
3. Ikkala E, Helske T, Myllylä G, Nevanlinna HR, Pitkänen P, Rasi V. Changes in the life expectancy of patients with severe haemophilia A in Finland in 1930-79. Br J Haematol 1982; 52: 7-12.
4. Plug I, Van Der Bom JG, Peters M et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006; 4: 510-6.
5. Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994; 236: 391-9.
6. Aznar JA, Magallón M, Querol F, Gorina E, Tusell JM. The orthopaedic status of severe haemophiliacs in Spain. Haemophilia 2000; 6: 170-6.
7. Hartl HK, Reitter S, Eidher U, Ramschak H, Ay C, Pabinger I. The impact of severe haemophilia on the social status and quality of life among Austrian haemophiliacs. Haemophilia 2008; 14: 703-8.
8. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999; 5: 378-85.
9. Royal S, Schramm W, Berntorp E et al. Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients. Haemophilia 2002; 8: 44-50.
10. Talaulikar D, Shadbolt B, McDonald A, Pidcock M. Health-related quality of life in chronic coagulation disorders. Haemophilia 2006; 12: 633-42.
11. Trippoli S, Vaiani M, Linari S, Longo G, Morfini M, Messori A. Multivariate analysis of factors influencing quality of life and utility in patients with haemophilia. Haematologica 2001; 86: 722-8.
12. Fischer K, Bom JG, Mauser-Bunschoten EP, Roosendaal G, Berg HM. Effects of haemophilic arthropathy on health-related quality of life and socio-economic parameters. Haemophilia 2005; 11: 43-8.
13. Fischer K, van der Bom JG, Molho P et al. Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome. Haemophilia 2002; 8: 745-52.
14. Molho P, Rolland N, Lebrun T et al. Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. Haemophilia 2000; 6: 23-32.
15. Scalone L, Mantovani LG, Mannucci PM, Gringeri A, COCIS Study Investigators. Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors. Haemophilia 2006; 12: 154-62.
16. Solovieva S. Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders. Haemophilia 2001; 7: 53-63.
17. Siboni SM, Mannucci PM, Gringeri A et al. Health status and quality of life of elderly persons with severe haemophilia born before the advent of modern replacement therapy. J Thromb Haemost 2009; 7: 780-6.
18. Rentz A, Flood E, Altisent C et al. Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia. Haemophilia 2008; 14: 1023-34.
19. van Genderen FR, Fischer K, Heijnen L et al. Pain and functional limitations in patients with severe haemophilia. Haemophilia 2006; 12: 147-53.
20. Oldenberg J, Goudemand J, Valentino L et al. Post-authorization safety surveillance of ADVATE [antihemophilic factor (recombinant), plasma/albumin-free method] demonstrates efficacy, safety and low-risk for immunogenicity in routine clinical practice. Haemophilia 2010; DOI.
21. Ware JE Jr, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User's Manual for the SF-36v2 Health Survey, 2nd edn. Lincoln, RI: QualityMetric Incorporated, 2007.
22. Ware JE Jr, Gandek B, Kosinski M et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1167-70.
23. Bullinger M, Von Mackensen S, Haemo-QoL Group. Quality of life in children and families with bleeding disorders. J Pediatr Hematol Oncol 2003; 25(Suppl. 1): S64-7.
24. Ravens-Sieberer U, Bullinger M. Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res 1998; 7: 399-407.
25. Wiedebusch S, Pollmann H, Siegmund B, Muthny FA. Quality of life, psychosocial strains and coping in parents of children with haemophilia. Haemophilia 2008; 14: 1014-22.
26. World Federation of Hemophilia. Report on the Annual Global Survey 2006. Montréal, QC: World Federation of Hemophilia, 2007.
27. Mulder K, Llinas A. The target joint. Haemophilia 2004; 10(Suppl. 4): 152-6.
28. Sherry DD. Avoiding the impact of musculoskeletal pain on quality of life in children with hemophilia. Orthop Nurs 2008; 27: 103-8.
29. Kern M, Blanchette V, Stain AM, Einarson TR, Feldman BM. Clinical and cost implications of target joints in Canadian boys with severe hemophilia A. J Pediatr 2004; 145: 628-34.
30. Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
31. Djulbegovic B, Goldsmith G, Vaughn D et al. Comparison of the quality of life between HIV-positive haemophilia patients and HIV-negative haemophilia patients. Haemophilia 1996; 2: 166-72.